Edistride
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Edistride, covering 2026-03-13 to 2026-06-11. Get the full timeline:
Most recent: EMA Authorised: Edistride (dapagliflozin propanediol monohydrate) — AstraZeneca AB